1-36097826-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005202.4(COL8A2):c.1855G>A(p.Val619Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,613,374 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005202.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL8A2 | ENST00000397799.2 | c.1855G>A | p.Val619Ile | missense_variant | 4/4 | 5 | NM_005202.4 | ENSP00000380901.1 | ||
COL8A2 | ENST00000481785.1 | c.1660G>A | p.Val554Ile | missense_variant | 2/2 | 1 | ENSP00000436433.1 | |||
COL8A2 | ENST00000303143.9 | c.1855G>A | p.Val619Ile | missense_variant | 2/2 | 2 | ENSP00000305913.4 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000717 AC: 18AN: 250988Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135794
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461128Hom.: 0 Cov.: 37 AF XY: 0.0000248 AC XY: 18AN XY: 726894
GnomAD4 genome AF: 0.000158 AC: 24AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74374
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.1855G>A (p.V619I) alteration is located in exon 2 (coding exon 2) of the COL8A2 gene. This alteration results from a G to A substitution at nucleotide position 1855, causing the valine (V) at amino acid position 619 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at